Insulet Corporation
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -19.3% | +93.8% | -0.9% | +13.5% | +49.9% | -56.8% | +208.0% | -36.0% | +45.8% | -37.9% | -22.3% | – | |
| – | +0.5% | +0.0% | +2.1% | +10.9% | +0.9% | +0.9% | +2.8% | -1.3% | +10.9% | +7.4% | +1.9% | – | |
| – | +20.0% | +12.7% | +19.7% | +6.5% | +10.5% | -9.0% | -58.8% | +122.7% | +21.6% | +4.9% | -8.0% | – | |
| – | – | – | – | – | – | -9,385.7% | – | -162.3% | – | -323.4% | – | – | |
| – | -91.1% | +1,100.0% | -6.3% | +18.7% | +109.7% | -78.0% | +88.6% | -9.5% | +543.3% | -79.4% | +4.3% | – | |
| – | +39.8% | -24.1% | +3.8% | +17.7% | +132.1% | -76.9% | +47.8% | +33.6% | +392.9% | -81.9% | +35.0% | – | |
| – | +10,700.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -50.0% | +4,900.0% | -78.0% | – | – | – | – | -2.0% | -100.0% | – | +0.0% | – | |
| – | – | – | – | – | +1,305.3% | – | -239.5% | +36.0% | -84.3% | -94.5% | +2.2% | – | |
| – | – | -740.9% | – | -11.4% | -367.9% | – | -223.7% | +33.0% | -84.1% | +341.2% | – | – | |
| – | -25.7% | +150.0% | +48.5% | +16.9% | -37.7% | +549.0% | -149.0% | – | – | – | – | – | |
| – | +40.5% | +34.7% | +1.1% | +11.7% | +27.7% | -43.8% | +236.5% | -39.6% | -54.0% | +78.4% | -30.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.